Webinar - Project Pulmona

Commercialising Respiratory Medicines

Treatment | Prevention | Cure

Project Pulmona is a clinical stage biopharmaceutical company developing drugs for respiratory diseases with a focus on Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD).

These two therapeutic areas have high medical need and high market values (e.g. US costs for COPD alone is >US$50 Billion p.a.).

Project Pulmona is looking to acquire a unique anti-infective drug and progress a merger and an acquisition and prepare for an ASX relisting.

At this event, attendees will have a chance to

• Get to know the Company;

• Meet the Team behind Project Pulmona;

• Receive the latest update from the Company;

• Gain insights on the current opportunity;

• Ask the questions you want answered.

Reserve Your Space